From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. (Q37034876)

17 August 2017

1 reference

title

From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. (English)

1 reference

17 August 2017

0 references

hepatocellular carcinoma

1 reference

Roberta W C Pang

1 reference

17 August 2017

Ronnie T P Poon

series ordinal

1 reference

17 August 2017

publication date

13 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

72 Suppl 1

1 reference

17 August 2017

page(s)

30-44

1 reference

Estimating the world cancer burden: Globocan 2000.

17 August 2017

cites work

1 reference

Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade

21 January 2018

1 reference

Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression

21 January 2018

1 reference

Genetic mechanisms of hepatocarcinogenesis

21 January 2018

1 reference

Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches

21 January 2018

1 reference

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.

21 January 2018

1 reference

mTOR and P70 S6 kinase expression in primary liver neoplasms

21 January 2018

1 reference

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

Convergence of Wnt, beta-catenin, and cadherin pathways

21 January 2018

1 reference

A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]

21 January 2018

1 reference

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

21 January 2018

1 reference

Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial

21 January 2018

1 reference

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

21 January 2018

1 reference

Low-dose thalidomide treatment for advanced hepatocellular carcinoma

21 January 2018

1 reference

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

21 January 2018

1 reference

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer

21 January 2018

1 reference

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

21 January 2018

1 reference

The potential role of hypoxia inducible factor 1alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-03-3311

Identifiers

DOI

10.1159/000111705

1 reference

17 August 2017

1 reference